Actively Recruiting
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Led by University of Kansas Medical Center · Updated on 2026-03-10
1000
Participants Needed
1
Research Sites
895 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
CONDITIONS
Official Title
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
- Patients can participate in any additional research studies during the patients' participation within this protocol.
You will not qualify if you...
- Patients who do not have presumed bladder cancer will not be eligible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Actively Recruiting
Research Team
J
Jane Ladesma
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here